HiFiBiO Therapeutics Announces Clinical Trial Supply Agreement to Evaluate HFB200603 in Combination with Tislelizumab in Patients with DIS™ Selected Advanced Solid Tumors Nov 18, 2022 By sarahjibrin
Nov 11, 2016 By Rick Bowen HiFiBiO SAS to present advances in functional therapeutic antibody discovery at The European Antibody Congress on Tuesday, November 15, 2016
Nov 7, 2016 By Rick Bowen HiFiBiO SAS to Present Advances in Functional Therapeutic Antibody Discovery with Two Talks at Human Antibodies and Hybridomas Conference to Be Held in Belfast, Northern Ireland, Wednesday, November 9, 2016
May 16, 2016 By Rick Bowen HiFiBiO SAS announces participation in next generation antibody therapeutics session along with Adimab, F-Star and Innovative Targeting Solutions at BioInternational 2016 in San Francisco, USA
Mar 23, 2016 By Rick Bowen HiFiBiO is Recognized as an “Innovative Start-up Company” by French President Francois Hollande at the Inauguration of the Institute Pierre-Gilles de Gennes
Nov 23, 2015 By Rick Bowen HiFiBiO SAS to Report Results from the First Fully Integrated, Single-Cell Antibody Discovery Platform at IBC Antibody and Engineering Therapeutics 2015 Conference
Oct 27, 2015 By Rick Bowen HiFiBiO’s next generation antibody discovery platform to be presented by Pfizer Inc. at PEGS Europe 2015
